This company has been marked as potentially delisted and may not be actively trading. NASDAQ:HSTO Histogen (HSTO) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Histogen Stock (NASDAQ:HSTO) Get Histogen alerts:Sign Up Key Stats Today's Range$0.0003▼$0.001350-Day Range N/A52-Week Range$0.05▼$0.55Volume1,625 shsAverage Volume10,369 shsMarket Capitalization$5.34 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Histogen, Inc. is a clinical‐stage biotechnology company headquartered in San Diego, California, that specializes in the development of regenerative medicine products for hair restoration and skin rejuvenation. The company’s proprietary technology harnesses the secreted growth factors, cytokines and extracellular matrix components produced by “embryonic‐like” human cells cultured under low‐oxygen conditions. By concentrating these biologically active molecules into a conditioned medium, Histogen aims to create off‐the‐shelf therapeutics that stimulate tissue repair and regeneration. Histogen’s lead product candidates include HST‐001, a formulation under investigation for accelerating wound healing and improving skin quality, and HST‐002, a topical treatment designed to promote hair follicle health and counteract androgenetic alopecia. Both programs have advanced through initial clinical evaluations, demonstrating favorable safety profiles and signs of biological activity. The company holds a portfolio of patents protecting its cell‐culture processes and methods of use in dermatological and aesthetic indications. Founded in 2007, Histogen operates research and GMP manufacturing facilities in the United States and collaborates with external laboratories and academic partners to expand its pipeline. Led by founder and Chief Executive Officer Christopher J. Bradley, the company continues to pursue late‐stage clinical development and strategic partnerships aimed at commercializing its regenerative therapeutics worldwide.AI Generated. May Contain Errors. Read More Receive HSTO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Histogen and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HSTO Stock News HeadlinesHistogen Inc COM NEW (OTC:HSTO) Stock, Short Interest ReportJuly 11, 2026 | benzinga.comHistogen Stock (OTC:HSTO) Dividends: History, Yield and DatesFebruary 6, 2024 | benzinga.comLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, protect it. This report normally sells for 29.97, but it's available as a free download for a limited time.November 1 at 1:00 AM | Profits Run (Ad)Histogen Announces Second Adjournment of Special Meeting of StockholdersDecember 14, 2023 | finance.yahoo.comHistogen Inc: Histogen Announces Adjournment of Special Meeting of StockholdersDecember 6, 2023 | finanznachrichten.deHistogen Announces Adjournment of Special Meeting of StockholdersDecember 5, 2023 | finance.yahoo.comHistogen Inc HSTONovember 1, 2023 | morningstar.comMWall Street Set to Open Wednesday Trading Higher as Investors Await Fed Decision on Interest RatesSeptember 21, 2023 | msn.comSee More Headlines HSTO Stock Analysis - Frequently Asked Questions How were Histogen's earnings last quarter? Histogen Inc. (NASDAQ:HSTO) released its quarterly earnings results on Wednesday, November, 10th. The company reported ($1.80) earnings per share for the quarter, beating analysts' consensus estimates of ($2.20) by $0.40. The firm had revenue of $590 thousand for the quarter. When did Histogen's stock split? Histogen's stock reverse split on Friday, June 3rd 2022.The 1-20 reverse split was announced on Friday, June 3rd 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, June 3rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. What other stocks do shareholders of Histogen own? Based on aggregate information from My MarketBeat watchlists, some other companies that Histogen investors own include Bionano Genomics (BNGO), Hepion Pharmaceuticals (HEPA), Ampio Pharmaceuticals (AMPE), GE Aerospace (GE), Castor Maritime (CTRM), Abeona Therapeutics (ABEO) and ADMA Biologics (ADMA). Company Calendar Last Earnings11/10/2021Today11/01/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:HSTO CIK1383701 Webwww.histogen.com Phone(858) 526-3100FaxN/AEmployees20Year Founded2007Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$19 thousand Price / Sales0.28 Cash FlowN/A Price / Cash FlowN/A Book Value$3.13 per share Price / Book0.00Miscellaneous Outstanding Shares4,270,000Free FloatN/AMarket Cap$5.34 thousand OptionableNot Optionable Beta1.19 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:HSTO) was last updated on 1/2/2026 by MarketBeat.com Staff. From Our PartnersFinancial Legend: “Big trouble ahead …”Dr. Martin D. Weiss, founder of Weiss Ratings and a two-time Congressional witness on financial institution ri...Weiss Ratings | SponsoredThe 401k Email 70 Million Investors Might DeleteAn email announcing a new 401k investment option is headed to roughly 70 million inboxes. Most recipients will...Brownstone Research | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredDr. Ron Paul’s Nov 3 election warningWashington has taken ownership stakes in roughly 30 companies since January 2025 - including an $8.9 billion s...Stansberry Research | SponsoredDoes your nest egg have an expiration date?A $250,000 nest egg growing at 5% a year and paying out $2,500 a month runs dry in just over a decade. Start w...Investors Alley | SponsoredYour free stock pick for todayElon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds, he...Behind the Markets | SponsoredCigar Lake Flooded Again Uranium Supply Shock RepeatsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the 50 range to 136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Histogen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Histogen With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
